Telegram Group & Telegram Channel
🌟 Navbatagi lmiy safar 🇫🇮!
Finlandiyaning Abo Akademi Universitetiga Professor Outi-Salo Achen taklifiga binoan bir oy davomida ilmiy safarga boraman. Ilg‘or Texnologiyalar Markazidagi "Inson va hayvonlarning patologik holatlari va kasalliklarining in silico imutatsion modellarini ishlab chiqish" nomli amaliy loyiha rahbari sifatida Abo Akademi olimlari – Dr. Phartiban Marimuthu va Prof. Outi Salo-Ahen bilan yaqin hamkorlik qilib kelmoqdaman. 🧪 Bu hamkorlik natijasida 6ta nufuzli jurnallarda qo‘shma maqolalar chop etildi. 📚
Safarda saraton, Parkinson, Altsgeymer va Xantington kabi nevrologik kasalliklarga qarshi samarali dori vositalarini bashorat qilish uchun dorilarni qayta yo'naltirish (Drug repurposing) texnikasidan foydalanib kompyuterda modellashtirish ishlarib olib boriladi. Avvalgi tadqiqotlarimizdan birida glioblastomaga qarshi FDA tomonidan tasdiqlangan 1379 dori ichidan eng samarali 4 tasini aniqlagan edik. Ushbu dorilarning ta’siri in-vitro tajribalarda ham o‘z tasdig‘ini topgan edi. Bu safar sarcoma va ko‘krak saratoni bo‘yicha tadqiqotlarga e’tibor qaratamiz.



tg-me.com/comp_sim_uz/973
Create:
Last Update:

🌟 Navbatagi lmiy safar 🇫🇮!
Finlandiyaning Abo Akademi Universitetiga Professor Outi-Salo Achen taklifiga binoan bir oy davomida ilmiy safarga boraman. Ilg‘or Texnologiyalar Markazidagi "Inson va hayvonlarning patologik holatlari va kasalliklarining in silico imutatsion modellarini ishlab chiqish" nomli amaliy loyiha rahbari sifatida Abo Akademi olimlari – Dr. Phartiban Marimuthu va Prof. Outi Salo-Ahen bilan yaqin hamkorlik qilib kelmoqdaman. 🧪 Bu hamkorlik natijasida 6ta nufuzli jurnallarda qo‘shma maqolalar chop etildi. 📚
Safarda saraton, Parkinson, Altsgeymer va Xantington kabi nevrologik kasalliklarga qarshi samarali dori vositalarini bashorat qilish uchun dorilarni qayta yo'naltirish (Drug repurposing) texnikasidan foydalanib kompyuterda modellashtirish ishlarib olib boriladi. Avvalgi tadqiqotlarimizdan birida glioblastomaga qarshi FDA tomonidan tasdiqlangan 1379 dori ichidan eng samarali 4 tasini aniqlagan edik. Ushbu dorilarning ta’siri in-vitro tajribalarda ham o‘z tasdig‘ini topgan edi. Bu safar sarcoma va ko‘krak saratoni bo‘yicha tadqiqotlarga e’tibor qaratamiz.

BY Computer_simulations_Uz


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/comp_sim_uz/973

View MORE
Open in Telegram


Computer_simulations_Uz Telegram | DID YOU KNOW?

Date: |

Mr. Durov launched Telegram in late 2013 with his brother, Nikolai, just months before he was pushed out of VK, the Russian social-media platform he founded. Mr. Durov pitched his new app—funded with the proceeds from the VK sale—less as a business than as a way for people to send messages while avoiding government surveillance and censorship.

How Does Telegram Make Money?

Telegram is a free app and runs on donations. According to a blog on the telegram: We believe in fast and secure messaging that is also 100% free. Pavel Durov, who shares our vision, supplied Telegram with a generous donation, so we have quite enough money for the time being. If Telegram runs out, we will introduce non-essential paid options to support the infrastructure and finance developer salaries. But making profits will never be an end-goal for Telegram.

Computer_simulations_Uz from jp


Telegram Computer_simulations_Uz
FROM USA